Drug Shortage Report for M-PRAVASTATIN

Last updated on 2025-11-17 History
Report ID 225548
Drug Identification Number 02476282
Brand name M-PRAVASTATIN
Common or Proper name M-PREVASTATIN
Company Name MANTRA PHARMA INC
Market Status MARKETED
Active Ingredient(s) PRAVASTATIN SODIUM
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-02-27
Estimated end date 2025-11-10
Actual end date 2025-11-13
Shortage status Resolved
Updated date 2025-11-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1000 RUE DU LUX SUITE 201
BROSSARD, QUEBEC
CANADA J4Y 0E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v40 2025-11-17 French Compare
v39 2025-11-17 English Compare
v38 2025-10-27 French Compare
v37 2025-10-27 English Compare
v36 2025-10-14 French Compare
v35 2025-10-14 English Compare
v34 2025-10-01 French Compare
v33 2025-10-01 English Compare
v32 2025-09-29 French Compare
v31 2025-09-29 English Compare
v30 2025-07-31 French Compare
v29 2025-07-31 English Compare
v28 2025-07-02 French Compare
v27 2025-07-02 English Compare
v26 2025-06-09 French Compare
v25 2025-06-09 English Compare
v24 2025-05-02 French Compare
v23 2025-05-02 English Compare
v22 2025-04-08 French Compare
v21 2025-04-08 English Compare

Showing 1 to 20 of 40